Invex Therapeutics Ltd News

Invex Therapeutics Ltd: Date of AGM and Closing Date for Director Nominations

Sep 23 02:22 ET

Invex Therapeutics Ltd: Appendix 4G and Corporate Governance Statement

Aug 22 02:14 ET

Invex Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 23 01:34 ET

Invex Therapeutics Ltd: Final Director's Interest Notice

Jun 30 18:22 ET

Invex Therapeutics Ltd: Invex receives R&D Tax Rebate

Jun 20 21:28 ET

Invex Therapeutics Ltd: Details of Auditor Appointment/Resignation

Apr 18 23:43 ET

Invex Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 12 00:49 ET

Invex Therapeutics Ltd: Change of Director's Interest Notice

Apr 8 23:16 ET

Invex Therapeutics Ltd: Change of Director's Interest Notice

Apr 2 20:16 ET

Invex Therapeutics Ltd: Amendment to Appendix 3A.4

Mar 21 22:09 ET

Invex Therapeutics Ltd: Update on R&D Tax Rebate from UK Government

Mar 4 18:26 ET

Invex Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jan 10 23:50 ET

Invex Therapeutics Ltd: Invex and Peptron Mutually Terminate Manufacturing Agreement

Dec 21, 2023 16:24 ET

Invex Therapeutics Ltd: Chair's Address to Shareholders

Nov 27, 2023 21:42 ET

Invex Therapeutics Ltd: Change of Director's Interest Notice x 3

Nov 27, 2023 04:08 ET

Invex Therapeutics Ltd: Invex Granted European Patent for Exenatide in Hydrocephalus

Nov 21, 2023 16:14 ET

Invex Therapeutics Ltd: Initial Director's Interest Notice

Nov 8, 2023 20:03 ET

Invex Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Oct 12, 2023 00:54 ET

Invex Therapeutics Ltd: Date of AGM and Closing Date for Director Nominations

Sep 25, 2023 02:14 ET

Invex Therapeutics Ltd: Change of Director's Interest Notice

Aug 24, 2023 19:20 ET